Information on New Approvals and Medication Safety
Search results for: primary care providers
Update on Meaningful Use
On December 30, the U.S. Department of Health and Human Services (HHS) released the long-awaited proposed rule establishing the Electronic Health Record (EHR) Incentive Program, which lays out a set of standards, implementation specifications, and certification criteria for EHR technology. This program has been developed in response to the “American Recovery and Reinvestment Act” (ARRA), which authorizes the Centers for Medicare & Medicaid Services to provide a reimbursement incentive for physician and hospital providers who become “meaningful users” of an EHR.
A Sobering Reality in Sierra Leone
Trip to focus on lupus takes on another purpose
H1N1 Influenza A Virus Brings Many Questions, Few Answers
Rheumatologists grapple with vaccine concerns and the impact of medications on response
Drug Updates
Information on New Approvals and Medication Safety
REMS Required
How will this FDA drug safety program affect rheumatology offices?
Quality Measures and Reporting
A call for professional responsibility
Members Comment on Drug Safety
The ACR recently conducted a survey of U.S. members about the issue of drug safety, sources of information, and related issues. The survey netted 454 responses.
Reduce the Danger of Falls
Common factors in arthritis patients increase falls risk
Patient Fact Sheet: Rheumatoid Arthritis
Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. RA is classified as an autoimmune disease, which develops because certain cells of the immune system malfunction and attack healthy joints.